Table 2.
Renal outcome and mortality 30 days, at discharge (after 58.3 +/− 21.8 days) and 90 days after admission N (%) or mean +/− SD; SCreat – serum creatinine, RRT - renal replacement therapy.
| All n = 116 |
Stage 1 AKI n = 24 (20.9%) |
Stage 2 AKI n = 15 (12.9%) |
Stage 3 AKI n = 37 (31.9%) |
||
|---|---|---|---|---|---|
| Baseline SCreat (mg/dL) | 1.03 +/− 0.21 | 1.08 ±0.41 | 1.05 +/− 0.26 | 1.02 +/− 0.19 | |
| 30 days | RRT | 22 (19.0%) | 0 (0%) | 3 (20.0%) | 17 (45.9%) |
| Dead | 19 (16.4%) | 4 (16.7%) | 2 (13.3%) | 8 (21.6%) | |
| SCreat (mg/dL) only alive and no RRT |
1.17 +/− 0.99 | 0.80 +/− 0.48 | 1.26 +/− 0.74 | 2.54 +/− 1.33 | |
| # of patients with worse SCreat (>150% baseline) | 14 of 68 (20.6%) | 1 of 19 (5.3%) | 3 of 10 (30%) | 8 of 11 (72.7%) | |
| Discharge | RRT | 2 (1.7%) | 0 (0%) | 0 (0%) | 2 (5.4%) |
| Dead | 35 (30.2%) | 9 (37.5%) | 6 (40.0%) | 13 (35.1%) | |
| SCreat (mg/dL) only alive and no RRT |
0.89 +/− 0.63 | 0.64 +/− 0.17 | 0.71 +/− 0.21 | 1.50 +/− 0.78 | |
| # of patients with worse SCreat (>150% baseline) | 10 of 78 (12.8%) | 0 of 4 (0%) | 0 of 2 (0%) | 9 of 22 (40.9%) | |
| 90 days | RRT | 2 (1.7%) | 0 (0%) | 0 (0%) | 2 (5.4%) |
| Dead | 35 (30.2%) | 9 (37.5%) | 6 (40.0%) | 13 (35.1%) | |
| SCreat (mg/dL) only alive and no RRT |
1.22 +/− 0.70 | 0.7+/− 0.0.35 | 0.63 +/− 0.07 | 1.50 +/− 0.66 | |
| # of patients with worse SCreat (>150% baseline) | 8 of 32 (25%) | 0 of 4 (0%) | 0 of 2 (0%) | 7 of 18 (38.9%) | |